Xarelto is heavily marketed as a simple drug to prescribe for patients with DVT and AFIB. Warfarin required the patient to undergo frequent blood tests
and restrict their diet. The blood work was monitored by the physicians to ensure that the Warfarin dosage was adjusted properly. Xarelto was promoted as a way to cope with taking anticoagulants for patients. Xarelto promises a "one dose fits all" dosage without the blood work and dietary restrictions. Unfortunately, the prescription drug Xarelto does not meet these claims for all patients.